Exact Sciences Corp (NAS:EXAS)
$ 54.745 0.025 (0.05%) Market Cap: 10.13 Bil Enterprise Value: 11.91 Bil PE Ratio: 0 PB Ratio: 3.16 GF Score: 80/100

Exact Sciences Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 07:15PM GMT
Release Date Price: $58.82 (+24.65%)
Unidentified Analyst

Hello. Thank you, everyone, for coming today. It's my pleasure to introduce Exact Sciences. Today, we'll be joined by Kevin Conroy, who's the Chairman and the CEO of the company, who will be providing the presentation. And then we will also be joined by Jeff Elliott, who is the CFO and COO; and Everett Cunningham, who's the CCO for Q&A. Handing it over. Thank you.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO

Thank you, Zach. Thanks JPMorgan for having us attend and present and to all those on the webcast and here, thanks for joining. We will be making forward-looking statements. This is our safe harbor statement. Remember these numbers, 1, 5, 7, 9, 14 and 10 million.

In 2009, I had a meeting that changed everything. I got a call from the Exact Sciences Board. They were looking for a CEO to effectively restart the company and develop a non-invasive colon cancer screening test. And the only problem is they had no R&D team left after a decade of work and no real proof of concept. So they suggested

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot